Earlier this year, Boston-based firm LumeNXT, which is a privately-held company, made an announcement regarding the changes in their leadership. As of April 2, their new Chairman of the Board is now Marc Beer, who is also known for his leadership role in another pharmaceutical company, Renovia. LumeNXT believes that through Beer’s leadership, the company will reach new heights.
Marc Beer, who is known in the pharmaceutical world because of his work in the commercialization of experience in biotech, diagnostics, and more, is very excited in this appointment. He revealed that he is happy to work with surgeons and engineers who are the best in their fields. Beer also believes that LumeNXT, which offers a highly innovative lightning unit for operations, will play a big role in the overall development of minimally invasive approaches. Beer also believes that because of its benefits, minimally invasive procedures will be the next normal in the medical world.
LumeNXT uses proprietary technology to provide illumination during surgery. Each LumeNXT product is designed to give advanced illumination while reducing the overall heat generated. Targeted illumination enhances the visualization and precision of medical professionals in the operating room. In addition, the targeted illumination technique gives flexibility during the operation. With this in mind, LumeNXT products are designed to be low-cost and disposable yet safe and give the enhanced visualization needed in an operation.
Paul Rhyme, the co-founder of LumeNXT, believes in the 25 years of Marc Beer’s competent record. Rhyme stated that Beer’s high level of success when it comes to setting up and growing multiple startups speaks a lot of demonstration of skills. With Beer’s vast experiences in companies, he would be able to guide LumeNXT in its plan of global commercialization. In addition, Rhyme also believes that with Beer’s help, the company will be on its way to profitability. Paul Rhyme was also named the Chief Executive Officer of the company last April. He also got Beer’s support for this achievement. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
This is not the only current venture of Marc Beer when it comes to pharmaceuticals. Beer is also one of the key players of Renovia, which was launched recently. Renovia is a company which is designed to diagnose and treat women who are suffering from Pelvic Floor Disorders. As of now, Beer was able to get the necessary funding to continue Renovia’s project. As of now, the company is planning to develop products which helps a lot of people from urinary incontinence.
Marc Beer is known for his 25 years of expertise in the pharmaceutical field. He was the founding chairman of the Minerva Neurosciences Inc, as well as the founding chairman of the Good Start Genetics. Beer was also the founding chairman of Good Start Genetics and the former CEO of ViaCell. Follow Marc Beer on Facebook